StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.42+0.07 (+0.84%)

Close on Nov 16, 2026Market cap $3.15BP/E –Yield –

Bausch Health Companies r&d expenses

Research and development expenses are spending on new products and technology.

Bausch Health Companies's R&D Expenses for the twelve months ending Sep 30, 2026 was $638.00M, up 1.1% year over year. For fiscal 2025 it was $629.00M, up 2.1% from the year before. Over ten years it grew 6.5% a year on average. The highest annual figure on record is $629.00M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$629.00M+2.1%
FY2024Dec 31, 2024$616.00M+2.0%
FY2023Dec 31, 2023$604.00M+14.2%
FY2022Dec 31, 2022$529.00M+13.8%
FY2021Dec 31, 2021$465.00M+2.9%
FY2020Dec 31, 2020$452.00M-4.0%
FY2019Dec 31, 2019$471.00M+14.0%
FY2018Dec 31, 2018$413.00M+14.4%
FY2017Dec 31, 2017$361.00M-14.3%
FY2016Dec 31, 2016$421.00M+26.0%
FY2015Dec 31, 2015$334.00M+35.8%
FY2014Dec 31, 2014$246.00M+56.9%
FY2013Dec 31, 2013$156.80M+98.2%
FY2012Dec 31, 2012$79.10M+20.4%
FY2011Dec 31, 2011$65.69M-3.8%
FY2010Dec 31, 2010$68.31M+43.6%
FY2009Dec 31, 2009$47.58M-31.8%
FY2008Dec 31, 2008$69.81M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$141.00M-15.1%
Q2 FY2026Jun 30, 2026$173.00M+8.8%
Q1 FY2026Mar 31, 2026$163.00M+14.0%
Q4 FY2025Dec 31, 2025$161.00M-1.2%
Q3 FY2025Sep 30, 2025$166.00M+13.7%
Q2 FY2025Jun 30, 2025$159.00M+1.9%
Q1 FY2025Mar 31, 2025$143.00M-5.3%
Q4 FY2024Dec 31, 2024$163.00M+7.2%
Q3 FY2024Sep 30, 2024$146.00M-4.6%
Q2 FY2024Jun 30, 2024$156.00M0.0%
Q1 FY2024Mar 31, 2024$151.00M+5.6%
Q4 FY2023Dec 31, 2023$152.00M+7.0%
Q3 FY2023Sep 30, 2023$153.00M+15.0%
Q2 FY2023Jun 30, 2023$156.00M+22.8%
Q1 FY2023Mar 31, 2023$143.00M+12.6%
Q4 FY2022Dec 31, 2022$142.00M+21.4%
Q3 FY2022Sep 30, 2022$133.00M+9.9%
Q2 FY2022Jun 30, 2022$127.00M+10.4%
Q1 FY2022Mar 31, 2022$127.00M+13.4%
Q4 FY2021Dec 31, 2021$117.00M-1.7%
Q3 FY2021Sep 30, 2021$121.00M+17.5%
Q2 FY2021Jun 30, 2021$115.00M+6.5%
Q1 FY2021Mar 31, 2021$112.00M-8.2%
Q4 FY2020Dec 31, 2020$119.00M+4.4%
Q3 FY2020Sep 30, 2020$103.00M-16.3%
Q2 FY2020Jun 30, 2020$108.00M-7.7%
Q1 FY2020Mar 31, 2020$122.00M+4.3%
Q4 FY2019Dec 31, 2019$114.00M-5.0%
Q3 FY2019Sep 30, 2019$123.00M+15.0%
Q2 FY2019Jun 30, 2019$117.00M+24.5%
Q1 FY2019Mar 31, 2019$117.00M+27.2%
Q4 FY2018Dec 31, 2018$120.00M+33.3%
Q3 FY2018Sep 30, 2018$107.00M+32.1%
Q2 FY2018Jun 30, 2018$94.00M0.0%
Q1 FY2018Mar 31, 2018$92.00M-4.2%
Q4 FY2017Dec 31, 2017$90.00M-3.2%
Q3 FY2017Sep 30, 2017$81.00M–
Q2 FY2017Jun 30, 2017$94.00M–
Q1 FY2017Mar 31, 2017$96.00M–
Q4 FY2016Dec 31, 2016$93.00M–

More Bausch Health Companies figures

See a number that looks wrong?